title: Cancer research in Brazil - stuck in second gear?
abstract: This article describes the main issues regarding clinical cancer research in Brazil, including both the opportunities and the hurdles. Scientists and clinicians in this field had the opportunity to talk to regulatory agencies and to the Health Ministry representative at a meeting held in the State of Rio de Janeiro, Brazil, in April 2014. Our conclusions are that we do indeed have opportunities; however, we need to move forward regarding partnerships between academia and industry, increase the availability of funding, and provide easier navigation through the regulatory processes.
authors.affiliation: Departamento de Imunologia, Instituto de Ciências Biomédicas, Universidade de São Paulo, São Paulo, SP, Brasil.
authors.forename: A P
authors.initials: AP
authors.lastname: Lepique
authors.affiliation: Instituto de Pesquisas Biomédicas, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, RS, Brasil.
authors.forename: C
authors.initials: C
authors.lastname: Bonorino
mesh_terms: D035843:Biomedical Research / Q000191:economics*; D001938:Brazil; D002986:Clinical Trials as Topic; D005378:Financial Support; D006801:Humans; D009313:National Health Programs; D009369:Neoplasms / Q000191:economics*; D012109:Research Support as Topic